chatterje
et
al
model
expect
outcom
india
object
assess
impact
appreci
magnitud
effect
indian
healthcar
servic
use
data
march
accord
jhu
indic
infect
india
chatterje
et
al
found
among
quarantin
scenario
effect
quarantin
citizen
india
would
becom
infect
effect
quarantin
would
result
million
infect
grim
number
suggest
solut
social
distanc
urgent
need
combat
epidem
minim
loss
life
lesson
learn
thu
far
largest
outbreak
pandem
china
us
itali
spain
reveal
still
cure
although
sever
possibl
drug
novel
agent
clinic
test
avail
compassion
use
repurpos
antivir
immunemodul
pharmacotherapi
india
like
also
test
repurpos
drug
carri
risk
search
pubm
term
reveal
close
studi
publish
diseas
countless
other
preprint
server
biorxiv
medrxiv
wealth
data
speed
inform
relat
aspect
astonish
histor
april
one
hope
treatment
emerg
convalesc
plasma
cp
immun
plasma
cp
plasma
collect
infect
individu
ie
human
plasma
transfus
infect
patient
postexposur
prophylaxi
unlik
immunoglobulin
igg
deriv
antibodi
plasmaderiv
monoclon
antibodi
cp
passiv
antibodi
therapi
show
success
neutral
antibodi
coronaviru
epidem
middl
east
respiratori
syndrom
mer
first
two
decad
cpderiv
antibodi
neutral
viru
prevent
replic
eg
complement
activ
phagocytosi
bind
without
interf
replic
china
five
critic
ill
patient
infect
also
acut
respiratori
distress
syndrom
receiv
transfus
igg
bind
titer
neutral
titer
day
admiss
clinic
statu
improv
three
discharg
day
hospit
note
patient
also
support
mechan
ventil
also
receiv
antivir
agent
combin
lopinavir
ritonavir
interferon
favipiravir
arbidol
andor
darunavir
methylprednisolon
steroid
global
current
effect
postinfect
prophylaxi
treatment
although
drug
repurpos
also
antibodi
prevent
like
month
antibodi
emerg
clinic
trial
cp
postinfect
treatment
shown
limit
moder
success
previous
mer
china
could
serv
shortterm
solut
suppress
mortal
rate
india
number
infect
increas
cp
infect
patient
could
donat
harvest
simultan
treatment
futur
use
effect
antibodi
discov
author
contribut
sole
intellectu
discuss
underli
studi
literatur
explor
write
review
edit
accept
respons
content
interpret
applic
author
declar
conflict
interest
relev
topic
r
e
f
e
r
e
n
c
e
